Fine Foods & Pharmaceuticals NTM SpA (9S5)
FSX
6.84
+0.08 (+1.18%)
Closed
Oct 7, 2026
Day's Range
6.846.84
52 wk Range
6.6411.85
Financial Statements - 9S5 - Fine Foods & Pharmaceuticals NTM SpA
Revenue
252.05M▲ 3.4%
Net Income
10.09M▲ 23.8%Net Margin 4.0%
EBITDA
36.43M▲ 11.4%
Free Cash Flow
-4.23M▼ 138.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 252.05M | 243.75M | 251.81M | 206.85M | 194.84M | 171.95M |
| Cost of Goods | 139.24M | 141.13M | 184.07M | 153.22M | 139.52M | 123.91M |
| Gross Profit | 112.81M | 102.61M | 67.73M | 53.62M | 55.32M | 48.03M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 17.20M | 15.40M | 7.12M | 284.92K | 7.35M | 5.84M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 13.57M | 11.83M | -1.85M | -14.19M | -4.59M | 16.68M |
| Income Tax | 3.47M | 3.67M | 1.66M | -4.69M | -3.16M | 3.31M |
| Net Income | 10.09M | 8.15M | -3.52M | -9.50M | -1.42M | 13.36M |
| EPS Basic | 0.41 | 0.32 | -0.14 | -0.37 | -0.06 | 0.58 |
| EPS Diluted | 0.41 | 0.32 | -0.14 | -0.37 | -0.06 | 0.55 |
| Basic Shares Outstanding | 24.62M | 25.48M | 25.15M | 25.56M | 23.94M | 23.18M |
| Diluted Shares Outstanding | 24.62M | 25.48M | 25.15M | 25.56M | 23.94M | 23.18M |
| Ebit | 16.45M | 15.12M | 2.95M | -12.16M | -3.88M | 17.16M |
| Ebitda | 36.43M | 32.70M | 20.30M | 13.67M | 20.92M | 22.42M |
| Net Income Continuous Operations | 10.09M | 8.15M | -3.52M | -9.50M | -1.42M | 13.36M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
